Search

Your search keyword '"Hovingh,GK"' showing total 378 results

Search Constraints

Start Over You searched for: Author "Hovingh,GK" Remove constraint Author: "Hovingh,GK" Language english Remove constraint Language: english
378 results on '"Hovingh,GK"'

Search Results

1. Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar

4. Reducing the clinical and public health Burden of Familial hypercholesterolemia

6. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

7. Defining the role of common variation in the genomic and biological architecture of adult human height

8. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (vol 50, pg 26, 2018)

9. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (vol 50, pg 765, 2017)

10. Biological interpretation of genome-wide association studies using predicted gene functions

11. Genetically Determined Height and Coronary Artery Disease

12. Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia

29. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis

31. Carriers of lecithin cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging [corrected].

32. Genetic studies of body mass index yield new insights for obesity biology

33. New genetic loci link adipose and insulin biology to body fat distribution

34. eNOS Activation by HDL Is Impaired in Genetic CETP Deficiency

35. Plasma proteomics improves prediction of coronary plaque progression.

36. Impact of cumulative LDL cholesterol and other risk factors on coronary artery disease prevalence in patients with familial hypercholesterolaemia.

37. The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study.

38. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.

39. The Role of Coronary Computed Tomography Angiography in the Diagnosis, Risk Stratification, and Management of Patients with Diabetes and Chest Pain.

40. Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia.

41. Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT): Outcomes by Sex.

42. Ursodeoxycholic Acid for Trans Intestinal Cholesterol Excretion Stimulation: A Randomized Placebo Controlled Crossover Study.

43. LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia.

44. Decreased LDL-Cholesterol Exposure Following ANGPTL3 Inhibition Reduces Coronary Plaque Development in Homozygous Familial Hypercholesterolemia.

45. Interleukin 6 plasma levels are associated with progression of coronary plaques.

46. Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotype.

47. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.

48. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.

49. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.

Catalog

Books, media, physical & digital resources